Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT OF EISNERAMPER LLP. - SOLIGENIX, INC. | fs12017ex23-1_soligenixinc.htm |
| EX-5.1 - OPINION OF DUANE MORRIS LLP. - SOLIGENIX, INC. | fs12017ex5-1_soligenixinc.htm |
| S-1 - REGISTRATION STATEMENT - SOLIGENIX, INC. | fs12017_soligenixinc.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
| Name | Ownership | State of Incorporation | ||||
| Enteron Pharmaceuticals, Inc. | 100.00 | % | Delaware | |||
| Orasomal Technologies Inc. | 75.30 | % | Delaware | |||
| DOR BioDefense Corp. | 100.00 | % | Delaware | |||
| Soligenix BioPharma Canada Incorporated | 100.00 | % | Canada | |||
| Soligenix UK Limited | 100.00 | % | United Kingdom | |||